• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol . Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China

tetano

Editor, Senior Moderator
J Clin Virol


. 2020 Oct 14;133:104661.
doi: 10.1016/j.jcv.2020.104661. Online ahead of print.
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China


Chunliang Lei[SUP] 1 [/SUP], Weiyin Lin[SUP] 1 [/SUP], Xilong Deng[SUP] 1 [/SUP], Fengyu Hu[SUP] 1 [/SUP], Fengjuan Chen[SUP] 1 [/SUP], Weiping Cai[SUP] 1 [/SUP], Yueping Li[SUP] 1 [/SUP], Chunyan Wen[SUP] 1 [/SUP], Yujuan Guan[SUP] 1 [/SUP], Jian Wang[SUP] 1 [/SUP], Xiaoting Chen[SUP] 1 [/SUP], Yi Cao[SUP] 1 [/SUP], Feng Li[SUP] 1 [/SUP], Xiaoping Tang[SUP] 2 [/SUP], Linghua Li[SUP] 3 [/SUP]



Affiliations
Free PMC article

Abstract

Background: Coronavirus Disease 2019 (COVID-19) is threatening billions of people. We described the clinical characteristics and explore virological and immunological factors associated with clinical outcomes.
Methods: 297 COVID-19 patients hospitalized in Guangzhou Eighth People's Hospital between January 20 and February 20, 2020 were included. Epidemiological, clinical and laboratory data were collected and analyzed. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in respiratory tract, blood samples and digestive tract was detected and lymphocyte subsets were tested periodically.
Result: Among the 297 patients (median age of 48 years), 154 (51.9 %) were female, 245 (82.5 %) mild/moderate cases, and 52 (17.5 %) severe/critical cases. 270 patients were detected for SARS-CoV-2 RNA in anal swabs and/or blood samples, and the overall positive rate was 23.0 % (62/270), higher in severe/critical cases than in mild/moderate cases (52.0 % vs. 16.4 %, P < 0.001). The CD4/CD8 ratio on admission was significantly higher in severe/critical cases than in mild/moderate cases (1.84 vs. 1.50, P = 0.022). During a median follow-up period of 17 days, 36 (12.1 %) patients were admitted to intensive care unit (ICU), 16 (5.4 %) patients developed respiratory failure and underwent mechanical ventilation, four (1.3 %) patients needed extracorporeal membrane oxygenation (ECMO), only one (0.34 %) patients died of multiple organ failure. Detectable SARS-CoV-2 RNA in anal swabs and/or blood samples, as well as higher CD4/CD8 ratio were independent risk factors of respiratory failure and ICU admission.
Conclusions: Most of COVID-19 patients in Guangzhou are mild/moderate, and presence of extrapulmonary virus and higher CD4/CD8 ratio are associated with higher risk of worse outcomes.

Keywords: CD4/CD8 ratio; COVID-19; Extrapulmonary; ICU admission; Respiratory failure; SARS-CoV-2; Virus.
 
Back
Top Bottom